Oppenheimer & Co. Inc. purchased a new stake in Doximity, Inc. (NASDAQ:DOCS – Get Rating) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 16,444 shares of the company’s stock, valued at approximately $497,000.
Several other large investors have also modified their holdings of DOCS. Truvestments Capital LLC bought a new stake in shares of Doximity in the 2nd quarter valued at about $32,000. Signaturefd LLC raised its holdings in shares of Doximity by 98.1% in the 3rd quarter. Signaturefd LLC now owns 1,050 shares of the company’s stock valued at $32,000 after purchasing an additional 520 shares in the last quarter. Sentry Investment Management LLC bought a new stake in shares of Doximity in the 3rd quarter valued at about $38,000. American International Group Inc. purchased a new position in shares of Doximity in the 2nd quarter worth approximately $43,000. Finally, CWM LLC grew its position in shares of Doximity by 540.4% in the 3rd quarter. CWM LLC now owns 1,460 shares of the company’s stock worth $44,000 after buying an additional 1,232 shares during the last quarter. Institutional investors own 52.48% of the company’s stock.
Doximity Trading Down 2.2 %
Shares of DOCS opened at $32.83 on Friday. The firm has a market capitalization of $6.36 billion, a P/E ratio of 59.69, a P/E/G ratio of 17.53 and a beta of 0.87. The firm has a 50-day moving average price of $33.94 and a 200 day moving average price of $32.25. Doximity, Inc. has a 12-month low of $22.91 and a 12-month high of $62.52.
Insider Transactions at Doximity
Analyst Ratings Changes
A number of research analysts have recently issued reports on the stock. Canaccord Genuity Group cut their price objective on shares of Doximity from $42.00 to $41.00 and set a “buy” rating on the stock in a research report on Friday, February 10th. Piper Sandler lifted their price objective on shares of Doximity from $35.00 to $38.00 in a research report on Friday, February 10th. Evercore ISI lifted their price objective on shares of Doximity from $28.00 to $32.00 in a research report on Friday, November 11th. Morgan Stanley downgraded shares of Doximity from an “equal weight” rating to an “underweight” rating and cut their price objective for the stock from $32.00 to $29.00 in a research report on Friday, January 6th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Doximity from $60.00 to $30.00 and set an “underweight” rating on the stock in a research report on Friday, February 17th. Three equities research analysts have rated the stock with a sell rating, three have issued a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $40.50.
Doximity Company Profile
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Featured Stories
- Get a free copy of the StockNews.com research report on Doximity (DOCS)
- Carvana Skidding On Revenue Decrease, Heavy Debt Burden
- What Are Consumer Staples Stocks?
- Is Rocky Brands Dividend A Good Fit For Your Portfolio?
- Beyond Meat Stock Is Not Beyond Hope
- Analysts Holding As Pfizer Waits On Two Phase 3 Studies
Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS – Get Rating).
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.
